Elanco Animal Health will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Key executives including CEO Jeff Simmons will join a fireside chat at 2:35 p.m. ET, discussing company strategy and outlook. The event will be webcast live and available for replay, providing investors with direct insights into Elanco's plans in animal health innovation and growth. This appearance highlights Elanco's commitment to transparency and engagement with the investment community.
Arete Research downgraded Uber's stock from Buy to Neutral with a $74 price target, citing an expected 64.95% drop in earnings per share to $1.09 despite 9.6% revenue growth to $14.76 billion. Uber faces new competition from Tesla's Cybercab, which o...
Wealthfront Corporation reported better-than-expected Q2 2026 earnings with $0.10 EPS versus $0.08 estimated and revenue of $91.87 million surpassing $91.53 million estimates. The company’s total platform assets grew 12% year-over-year to $99 billion...
Bitcoin traded near $80,000 after testing that level early September, with Ethereum and XRP also rising. Mexican billionaire Ricardo Salinas Pliego reiterated his bullish view, forecasting Bitcoin could reach $1.86 million by matching gold's market v...
Voyageur Pharmaceuticals has reached its first milestone in a collaboration with Bayer by submitting an approved feasibility plan, triggering a $1 million non-dilutive payment. This follows an earlier $350,000 payment, totaling $1.35 million of the $...
Eigen Labs hosted a quantum circuit optimization challenge that outperformed Google's benchmark for breaking Bitcoin and Ethereum cryptography by about 50%. Over 100 participants, including Ethereum Foundation and StarkWare researchers, improved the ...
